TAXOL - A UNIQUE ANTINEOPLASTIC AGENT WITH SIGNIFICANT ACTIVITY IN ADVANCED OVARIAN EPITHELIAL NEOPLASMS

被引：1124

作者：

MCGUIRE, WP ^{[1
]}

ROWINSKY, EK ^{[1
]}

ROSENSHEIN, NB ^{[1
]}

GRUMBINE, FC ^{[1
]}

ETTINGER, DS ^{[1
]}

ARMSTRONG, DK ^{[1
]}

DONEHOWER, RC ^{[1
]}

机构：

[1] JOHNS HOPKINS UNIV HOSP, BALTIMORE, MD 21205 USA

来源：

ANNALS OF INTERNAL MEDICINE | 1989年 / 111卷 / 04期

关键词：

D O I：

10.7326/0003-4819-111-4-273

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：273 / 279

页数：7

共 25 条

[1]

DECKER DG, 1982, OBSTET GYNECOL, V60, P481

[2]

DONEHOWER RC, 1987, CANCER TREAT REP, V71, P1171

[3] PRETREATMENT HIGH-RISK PATIENTS REQUIRING RADIOGRAPHIC CONTRAST-MEDIA STUDIES [J].

GREENBERGER, PA ;

PATTERSON, R ;

SIMON, R ;

LIEBERMAN, P ;

WALLACE, W .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1981, 67 (03) :185-187

[4] ADVANCED OVARIAN-CANCER - LONG-TERM RESULTS OF TREATMENT WITH INTENSIVE CISPLATIN-BASED CHEMOTHERAPY OF BRIEF DURATION [J].

HAINSWORTH, JD ;

GROSH, WW ;

BURNETT, LS ;

JONES, HW ;

WOLFF, SN ;

GRECO, FA .

ANNALS OF INTERNAL MEDICINE, 1988, 108 (02) :165-170

[5]

HAMEL E, 1981, J BIOL CHEM, V256, P1887

[6] LONG-TERM SURVIVAL OF ADVANCED REFRACTORY OVARIAN-CARCINOMA PATIENTS WITH SMALL-VOLUME DISEASE TREATED WITH INTRAPERITONEAL CHEMOTHERAPY [J].

HOWELL, SB ;

ZIMM, S ;

MARKMAN, M ;

ABRAMSON, IS ;

CLEARY, S ;

LUCAS, WE ;

WEISS, RJ .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (10) :1607-1612

[7]

KRIS MG, 1986, CANCER TREAT REP, V70, P605

[8]

KUMAR N, 1981, J BIOL CHEM, V256, P435

[9] PHASE-I STUDY OF TAXOL USING A 5-DAY INTERMITTENT SCHEDULE [J].

LEGHA, SS ;

TENNEY, DM ;

KRAKOFF, IR .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (05) :762-766

[10]

MACHIN D, 1987, STATISTICAL TABLES D, P54

← 1 2 3 →